SCHEMBL24729554

SCHEMBL24729554

CCCOC(=O)C1CN(Cc2ccccc2)CC12CCCCC2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
LMNA P02545 2/20 0.42
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
MAPT P10636 1/20 0.42
MAPK1 P28482 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.40
ATM Q13315 1/20 0.40
CHRM2 P08172 1/20 0.40
CHRM4 P08173 1/20 0.40
CHRM5 P08912 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40
SIGMAR1 Q99720 3/20 0.39
KDM4E B2RXH2 1/20 0.39
GAA P10253 1/20 0.39
CYP2D6 P10635 3/20 0.39
NPSR1 Q6W5P4 1/20 0.39
MME P08473 1/20 0.39
BCHE P06276 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16053764 0.91 L3MBTL1 (0.48) ALDH1A1LMNAKMT2AMEN1MAPT
SCHEMBL22864682 0.90 L3MBTL1 (0.49) ALDH1A1LMNAKMT2AMEN1MAPT
SCHEMBL30751751 0.87 L3MBTL1 (0.49) ALDH1A1LMNAKMT2AMEN1MAPT
SCHEMBL6356789 0.86 CYP2D6 (0.46) ALDH1A1LMNAKMT2AMEN1MAPT
SCHEMBL4509900 0.85 ALDH1A1 (0.50) ALDH1A1LMNAKMT2AMEN1MAPT
SCHEMBL30751712 0.80 SIGMAR1 (0.48) ALDH1A1LMNAKMT2AMEN1MAPT
SCHEMBL27329178 0.77 ALDH1A1 (0.47) ALDH1A1KMT2AMEN1L3MBTL1ATM
SCHEMBL31516363 0.77 CYP2D6 (0.51) ALDH1A1LMNAKMT2AMEN1MAPT
SCHEMBL4509125 0.76 ALDH1A1 (0.53) ALDH1A1LMNAKMT2AMEN1MAPT
SCHEMBL21685887 0.76 SIGMAR1 (0.47) ALDH1A1LMNAKMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220389037-A1 HPK1 INHIBITORS AND USES THEREOF REGOR PHARMACEUTICALS, INC. 2022-12-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220389037-A1 HPK1 INHIBITORS AND USES THEREOF HIPK1, SIK1, PGK1 ALDH1A1 3740/4885LMNA 3287/4885KMT2A 2256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.